| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.643.056 | 2.416.271 | 2.489.609 | 2.512.467 | 2.435.376 | 2.727.816 | 2.256.695 | 2.560.859 | 2.666.454 | 2.750.659 |
| Total Income - EUR | 898.754 | 2.416.288 | 2.489.624 | 2.517.470 | 2.867.654 | 2.727.829 | 2.256.695 | 2.560.873 | 2.666.471 | 2.750.674 |
| Total Expenses - EUR | 826.319 | 2.389.163 | 2.465.817 | 2.572.309 | 2.932.234 | 2.599.877 | 2.124.835 | 2.527.123 | 2.637.475 | 2.693.810 |
| Gross Profit/Loss - EUR | 72.435 | 27.125 | 23.807 | -54.839 | -64.580 | 127.952 | 131.861 | 33.750 | 28.997 | 56.864 |
| Net Profit/Loss - EUR | 61.238 | 22.280 | 19.965 | -54.839 | -64.580 | 123.531 | 110.761 | 28.157 | 24.357 | 47.437 |
| Employees | 46 | 55 | 60 | 59 | 62 | 0 | 0 | 0 | 61 | 56 |
Check the financial reports for the company - Nefrolmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 362.915 | 854.509 | 801.169 | 786.505 | 367.145 | 331.413 | 564.239 | 567.176 | 462.912 | 469.248 |
| Current Assets | 473.996 | 462.695 | 617.462 | 638.875 | 586.444 | 501.676 | 547.146 | 478.213 | 285.084 | 160.178 |
| Inventories | 198.112 | 216.231 | 337.706 | 357.497 | 525.623 | 317.266 | 470.153 | 146.144 | 80.178 | 73.092 |
| Receivables | 200.028 | 211.397 | 243.082 | 245.520 | 28.296 | 132.494 | 42.441 | 72.436 | 171.019 | 45.379 |
| Cash | 75.857 | 35.068 | 36.673 | 35.859 | 32.526 | 51.916 | 34.551 | 259.633 | 33.887 | 41.706 |
| Shareholders Funds | 194.633 | 214.928 | 20.009 | -35.197 | -99.096 | 26.314 | 136.492 | 59.237 | 52.484 | 99.628 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 642.278 | 1.102.277 | 1.398.622 | 1.460.577 | 1.052.685 | 806.776 | 974.892 | 986.152 | 695.512 | 529.798 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Nefrolmed S.r.l.